ClinicalTrials.Veeva

Menu

Pilot Safety Study of Injectable SIS for Critical Limb Ischemia (CLIC)

Cook Group logo

Cook Group

Status

Completed

Conditions

Peripheral Vascular Disease
Critical Limb Ischemia
Peripheral Arterial Disease

Treatments

Device: Injectable SIS

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

This study is intended to collect safety and effectiveness data on the Cook Injectable Small Intestinal Submucosa (SIS)

Enrollment

13 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of critical limb ischemia
  • Rutherford 4-5 or Leriche-Fontaine IIIB
  • Patient unable to be treated by endovascular or surgical means

Exclusion criteria

  • Patient's age is <21
  • Patient is pregnant or breast-feeding (or is planning to become pregnant within the next year)
  • Patient has had a previous surgery, within 30 days of the study procedure
  • Patient has any planned surgical or interventional procedure within 30 days after the study procedure
  • Patient has a life expectancy less than 1 year
  • Patient has a known allergy to pigs or pig products, or has a religious or cultural objection to the use of pig tissue
  • Additional restrictions as specified in the Clinical Investigation Plan

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

13 participants in 1 patient group

Treatment
Experimental group
Description:
Injectable SIS
Treatment:
Device: Injectable SIS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems